P3 Health Partners Inc (NAS:PIII)
$ 9.83 -0.46 (-4.47%) Market Cap: 32.69 Mil Enterprise Value: 341.61 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 43/100

Q4 2024 P3 Health Partners Inc Earnings Call Transcript

Mar 27, 2025 / 08:30PM GMT
Release Date Price: $9.04 (+1.52%)

Key Points

Positve
  • P3 Health Partners Inc (PIII) reported a 13% membership growth and a 7% increase in revenue for the fourth quarter of 2024.
  • The company reaffirmed its 2025 revenue guidance of $1.35 billion to $1.5 billion and expects to achieve profitability this year.
  • P3 Health Partners Inc (PIII) has significantly enhanced its senior leadership team with key new hires, bringing substantial industry experience.
  • The company is on track to realize a $130 million plus EBITDA improvement opportunity through operational efficiencies, contract rationalization, and operational execution.
  • P3 Health Partners Inc (PIII) has introduced innovative programs like P3 Restore to reduce physician burnout, which is expected to improve patient outcomes and clinician tenure.
Negative
  • The fourth quarter medical margin decreased year over year due to elevated utilization trends.
  • Adjusted EBITDA for the fourth quarter was a loss of $68 million, including unfavorable out-of-period true-ups related to a single payer partner.
  • Full-year medical margin decreased by approximately 37% year over year, driven by elevated medical expenses, especially Part D expenses.
  • Adjusted EBITDA loss for the full year 2024 was $167.2 million, compared to a loss of $85.5 million in the prior year.
  • The company faced increased unit costs and higher utilization of elective or surgical procedures, contributing to overall higher costs.
Operator

Good day and welcome to the P3 Health Partners 4th quarter 2024 earnings conference call. All participants will be in a listen-only mode. Should you need assistance, please signal conference specialists by pressing the star key followed by 0. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star then 1 on your touchtone phone. And to withdraw your question, please press star, then 2. Please note this event is being recorded. I would now like to turn the conference over to Mr. Ryan Halstead of Investor Relations. Please go ahead, sir.

Ryan Halstead
Gilmartin Group LLC - Analyst

Thank you, operator, and thank you for joining us today. Before we proceed with the call, I would like to remind everyone that certain statements made during this call are forward-looking statements under the US Federal securities laws, including statements regarding our financial outlook and long-term targets. These forward-looking statements are only predictions and are based largely on our current expectations and projections

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot